Optimized conditions for gene transduction into primary immune cells using viral vectors.

Kim, Yeongrin; Lee, Da Yeon; Choi, Ji U; Park, Jin Song; Lee, So Myoung; Kang, Chung Hyo; Park, Chi Hoon

Kim, Yeongrin; Lee, Da Yeon; Choi, Ji U; Park, Jin Song; Lee, So Myoung; Kang, Chung Hyo; Park, Chi Hoon.

Afiliación

Kim Y; Bio and Drug Discovery Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, PO Box 107, Daejeon, 34114, Republic of Korea.
Lee DY; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, 34316, Republic of Korea.
Choi JU; Bio and Drug Discovery Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, PO Box 107, Daejeon, 34114, Republic of Korea.
Park JS; College of Pharmacy, Chungnam National University, Daejeon, 34134, Republic of Korea.
Lee SM; Bio and Drug Discovery Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, PO Box 107, Daejeon, 34114, Republic of Korea.
Kang CH; Medicinal Chemistry and Pharmacology, Korea University of Science and Technology, Daejeon, 34316, Republic of Korea.
Park CH; Bio and Drug Discovery Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, PO Box 107, Daejeon, 34114, Republic of Korea.

Sci Rep ; 13(1): 12365, 2023 07 31.

Article en En | MEDLINE | ID: mdl-37524755

Asunto(s)

Vectores Genéticos; Neoplasias; Humanos; Transducción Genética; Vectores Genéticos/genética; Células Asesinas Naturales; Linfocitos T; Inmunoterapia Adoptiva/métodos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vectores Genéticos / Neoplasias Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google